| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PGEN | PRECIGEN INC | $1.54B | $4.29 | $13.67 | 218.58% | Strong Buy | 3 | 55.59% | 94.71% | 327.34% | 129.32% | |||
| CORT | CORCEPT THERAPEUTICS INC | $7.67B | $70.07 | $137.25 | 95.88% | Buy | 4 | 33.82% | 72.40% | 147.62% | 119.02% | |||
| FENC | FENNEC PHARMACEUTICALS INC | $479.44M | $13.58 | $17.00 | 25.18% | Strong Buy | 3 | 29.14% | 246.49% | 162.89% | 95.91% | |||
| TGTX | TG THERAPEUTICS INC | $9.48B | $62.71 | $65.40 | 4.29% | Buy | 5 | 23.75% | 72.24% | 105.63% | 37.96% | |||
| LGND | LIGAND PHARMACEUTICALS INC | $5.88B | $293.81 | $355.38 | 20.95% | Strong Buy | 8 | 22.65% | 76.54% | 29.30% | 12.59% | |||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $3.46B | $27.33 | $42.00 | 53.68% | Strong Buy | 5 | 19.63% | 105.84% | 137.36% | 63.90% | |||
| RPRX | ROYALTY PHARMA PLC | $39.40B | $68.68 | $68.00 | -0.99% | Strong Buy | 5 | 14.36% | 60.96% | 42.05% | 21.16% | |||
| KRYS | KRYSTAL BIOTECH INC | $8.85B | $298.55 | $394.83 | 32.25% | Strong Buy | 6 | 22.56% | 18.05% | 60.39% | 54.66% | |||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $7.47B | $95.11 | $102.75 | 8.03% | Strong Buy | 8 | 18.78% | 18.48% | 35.25% | 25.46% | |||
| HALO | HALOZYME THERAPEUTICS INC | $10.94B | $95.97 | $118.63 | 23.61% | Buy | 8 | 9.77% | 43.39% | -2,008.38% | 31.94% | |||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $15.45B | $240.71 | $300.83 | 24.98% | Strong Buy | 18 | 5.32% | 104.41% | 48.77% | 17.04% | |||
| ADMA | ADMA BIOLOGICS INC | $3.02B | $13.63 | $15.00 | 10.05% | Buy | 2 | 12.73% | 13.59% | 76.72% | 45.93% | |||
| VCEL | VERICEL CORP | $2.95B | $57.88 | $66.50 | 14.89% | Strong Buy | 4 | 13.06% | 27.58% | 21.81% | 16.21% | |||
| TECH | BIO-TECHNE CORP | $11.41B | $72.63 | $71.86 | -1.06% | Hold | 9 | 8.03% | 33.47% | 18.89% | 15.52% | |||
| ZVRA | ZEVRA THERAPEUTICS INC | $559.34M | $9.40 | $24.00 | 155.32% | Strong Buy | 8 | 15.85% | 5.21% | 70.94% | 54.05% | |||
| VRTX | VERTEX PHARMACEUTICALS INC | $135.44B | $534.20 | $588.93 | 10.25% | Strong Buy | 14 | 9.04% | 15.38% | 35.97% | 22.97% | |||
| INCY | INCYTE CORP | $24.27B | $119.09 | $131.61 | 10.51% | Buy | 18 | 3.39% | 69.62% | 14.53% | 11.25% | |||
| EXEL | EXELIXIS INC | $16.71B | $68.50 | $59.33 | -13.38% | Hold | 12 | 10.23% | 14.93% | 66.23% | 48.32% | |||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.94B | $33.01 | $47.67 | 44.40% | Buy | 6 | 10.71% | 15.01% | 21.84% | 15.84% | |||
| REGN | REGENERON PHARMACEUTICALS INC | $99.08B | $957.76 | $911.12 | -4.87% | Strong Buy | 25 | 9.56% | 19.16% | 22.88% | 17.26% | |||
| UTHR | UNITED THERAPEUTICS CORP | $24.88B | $584.10 | $647.60 | 10.87% | Buy | 10 | 8.83% | 8.99% | 30.85% | 27.53% | |||
| CYPH | CYPHERPUNK TECHNOLOGIES INC | $205.29M | $1.91 | $4.95 | 159.84% | Strong Buy | 2 | N/A | 20.22% | -18.15% | -17.68% | |||
| VCYT | VERACYTE INC | $1.96B | $24.23 | $42.78 | 76.55% | Buy | 9 | 6.10% | 4.67% | 11.51% | 10.49% |